Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Efficacy and safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in US pediatric patients with primary immunodeficiency disease

Niraj Patel, Jolan Walter,Richard Wasserman,Arye Rubinstein,T Prescott Atkinson,Meagan Shepherd,Erin Greco, Sharon Russo-Schwarzbaum,Kimberly Duff,Barbara McCoy, Liang-Hui Chu,Zhaoyang Li,Leman Yel

Clinical Immunology（2023）

Cited 0|Views18
No score
Key words
Anti-rHuPH20 antibodies,Efficacy,Facilitated subcutaneous immunoglobulin,Hyaluronidase,Pediatric,Phase 3,PIDD,Primary immunodeficiency disease,Replacement therapy,Safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined